Bret Coldren

Title: Bret Coldren: Innovator in Alpha-1 Proteinase Inhibitor Research

Introduction

Bret Coldren is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of biochemistry, particularly in the development of compositions related to alpha-1 proteinase inhibitors. His work is essential for advancing therapeutic options for patients with specific protein deficiencies.

Latest Patents

Bret Coldren holds a patent for a "Composition, method, and kit for alpha-1 proteinase inhibitor." This invention provides compositions that comprise alpha-1 proteinase inhibitor (API) and at least one amino acid. The patent details a liquid API formulation that incorporates amino acids, which enhance the stability of the API formulation. This innovation is crucial for improving the efficacy and shelf-life of therapeutic products.

Career Highlights

Bret Coldren is currently employed at Grifols Therapeutics Inc., a company known for its commitment to developing life-saving therapies. His role at Grifols Therapeutics allows him to apply his expertise in biochemistry and contribute to the advancement of medical treatments.

Collaborations

Throughout his career, Bret has collaborated with talented individuals such as Jianxin Guo and Anthony Klos. These collaborations have fostered a productive environment for innovation and research, leading to significant advancements in their field.

Conclusion

Bret Coldren's work in the development of alpha-1 proteinase inhibitors showcases his dedication to improving healthcare solutions. His innovative patent and collaborations highlight the importance of teamwork in scientific research.